274 related articles for article (PubMed ID: 29984884)
21. Relationship between blood pressure and kidney diseases in large randomized controlled trials: secondary analyses using SPRINT and ACCORD-BP trials.
Wang L; Pezeshkian K; Rayamajhi S; Herzallah K; Al-Abcha A; Olomu A; Kelly-Blake K; Yu E; Wang DH
J Hum Hypertens; 2021 Oct; 35(10):859-869. PubMed ID: 33093616
[TBL] [Abstract][Full Text] [Related]
22. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
[TBL] [Abstract][Full Text] [Related]
23. Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease.
Chang TI; Wei G; Boucher R; Kramer H; Chertow GM; Cheung AK; Greene T; Whelton PK; Beddhu S
Kidney360; 2020 May; 1(5):368-375. PubMed ID: 35369376
[TBL] [Abstract][Full Text] [Related]
24. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
[TBL] [Abstract][Full Text] [Related]
25. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.
Azushima K; Wakui H; Uneda K; Haku S; Kobayashi R; Ohki K; Kinguchi S; Haruhara K; Fujikawa T; Toya Y; Umemura S; Tamura K
Clin Exp Hypertens; 2017; 39(7):665-671. PubMed ID: 28635327
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
27. Systolic blood pressure trajectory and cardiovascular outcomes: An analysis using data in the Systolic Blood Pressure Intervention Trial.
Lee CL; Wang JS
Int J Clin Pract; 2020 Mar; 74(3):e13450. PubMed ID: 31755625
[TBL] [Abstract][Full Text] [Related]
28. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
[TBL] [Abstract][Full Text] [Related]
29. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
[TBL] [Abstract][Full Text] [Related]
30. Relationship between orthostatic blood pressure changes and intensive blood pressure management in patients with hypertension.
Pei J; Zhang H; Li Y; Yan J; Zheng K; Wang X; Zheng XL; Hu X
Heart; 2022 Dec; 109(2):111-118. PubMed ID: 36007937
[TBL] [Abstract][Full Text] [Related]
31. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.
Li C; Chen K; Shi G; Shi R; Wu Z; Yuan X; Watson V; Jiang Z; Mai H; Yang T; Wang D; Chen T
BMC Med; 2022 Jun; 20(1):208. PubMed ID: 35718771
[TBL] [Abstract][Full Text] [Related]
32. Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial.
Dieter BP; Daratha KB; McPherson SM; Short R; Alicic RZ; Tuttle KR
Am J Nephrol; 2019; 49(5):359-367. PubMed ID: 30939480
[TBL] [Abstract][Full Text] [Related]
33. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
Widimský J
Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
[TBL] [Abstract][Full Text] [Related]
34. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
[TBL] [Abstract][Full Text] [Related]
35. Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).
Chang TI; Reboussin DM; Chertow GM; Cheung AK; Cushman WC; Kostis WJ; Parati G; Raj D; Riessen E; Shapiro B; Stergiou GS; Townsend RR; Tsioufis K; Whelton PK; Whittle J; Wright JT; Papademetriou V;
Hypertension; 2017 Oct; 70(4):751-758. PubMed ID: 28760939
[TBL] [Abstract][Full Text] [Related]
36. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.
Obi Y; Kalantar-Zadeh K; Shintani A; Kovesdy CP; Hamano T
J Intern Med; 2018 Mar; 283(3):314-327. PubMed ID: 29044764
[TBL] [Abstract][Full Text] [Related]
37. Association of Estimated Pulse Wave Velocity With Survival: A Secondary Analysis of SPRINT.
Vlachopoulos C; Terentes-Printzios D; Laurent S; Nilsson PM; Protogerou AD; Aznaouridis K; Xaplanteris P; Koutagiar I; Tomiyama H; Yamashina A; Sfikakis PP; Tousoulis D
JAMA Netw Open; 2019 Oct; 2(10):e1912831. PubMed ID: 31596491
[TBL] [Abstract][Full Text] [Related]
38. The Benefits of Intensive Versus Standard Blood Pressure Treatment According to Fine Particulate Matter Air Pollution Exposure: A Post Hoc Analysis of SPRINT.
Al-Kindi SG; Brook RD; Bhatt U; Brauer M; Cushman WC; Hanson HA; Kostis J; Lash JP; Paine R; Raphael KL; Rapp S; Tamariz L; Wright JT; Rajagopalan S;
Hypertension; 2021 Mar; 77(3):813-822. PubMed ID: 33517683
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
[TBL] [Abstract][Full Text] [Related]
40. Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT.
Smith C; Berry JD; Scherzer R; de Lemos JA; Nambi V; Ballantyne CM; Kravitz RL; Killeen AA; Ix JH; Shlipak MG; Ascher SB
J Am Heart Assoc; 2024 Mar; 13(6):e032493. PubMed ID: 38497469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
